Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

30 disclosures
10 insiders
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
REGN / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

Julia Letlow, Representative

buy disclosed on 12 Mar 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Gilbert Cisneros, Representative

buy disclosed on 15 Dec 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Rob Bresnahan, Representative

buy disclosed on 9 Jun 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Byron Donalds, Representative

sell disclosed on 24 May 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Byron Donalds, Representative

sell disclosed on 24 May 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Julie Johnson, Representative

sell disclosed on 14 May 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jefferson Shreve, Representative

sell disclosed on 8 May 2025 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Rob Bresnahan, Representative

sell disclosed on 8 May 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Rob Bresnahan, Representative

sell disclosed on 27 Mar 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Julie Johnson, Representative

sell disclosed on 12 Mar 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Julie Johnson, Representative

buy disclosed on 12 Feb 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

sell disclosed on 12 Dec 2024 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

sell disclosed on 12 Dec 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 5 Dec 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 5 Dec 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Greg Landsman, Representative

sell disclosed on 14 Nov 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 6 Nov 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 15 Aug 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Greg Landsman, Representative

buy disclosed on 14 Aug 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 7 Mar 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

buy disclosed on 15 Feb 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 8 Dec 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

buy disclosed on 16 Sept 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

buy disclosed on 21 Aug 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 11 Jul 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

buy disclosed on 7 Jul 2023 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 20 Apr 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Thomas Suozzi, Representative

sell disclosed on 19 Dec 2022 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

buy disclosed on 10 Nov 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

buy disclosed on 16 Oct 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%